Ocular Therapeutix OCUL reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Ocular Therapeutix beat estimated earnings by 13.79%, reporting an EPS of $-0.25 versus an estimate of $-0.29.
Revenue was up $3.12 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 10.78% drop in the share price the next day.
Here's a look at Ocular Therapeutix's past performance:
Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
---|---|---|---|---|
EPS Estimate | -0.29 | -0.26 | -0.25 | -0.24 |
EPS Actual | -0.26 | -0.39 | -0.24 | -0.31 |
Revenue Estimate | 14.64M | 14.10M | 13.53M | 14.27M |
Revenue Actual | 15.19M | 13.37M | 14.08M | 11.96M |
To track all earnings releases for Ocular Therapeutix visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.